Table 1 Age, gender, pathological diagnosis, treatment, and outcome in patients with primary sacral lymphoma reported in literature till December 2020
From: Primary sacral non-Hodgkin’s lymphoma: report of a case and systematic review of literature
Author and year [Ref] | Age | Gender | Histology | Treatment | Follow-up | Outcome |
|---|---|---|---|---|---|---|
Nayil K et al. 2011 [9] | 56 | M | NHL-B cell no further categorization | S1-S2 laminectomy + RT | 6 months | Well |
Shimada A et al. 2013 [10] | 85 | M | Non GC type DLBCL, EBV, Myc translocation | R-CHOP | 12 months | CR, disease free |
Xu T et al. 2020 [13] | 84 | F | DLBCL | R-CHOP | 5 months | CMR |
Li GN et al. 2020 [6] | 77 | M | DLBCL | R-CHOP | 1 month | On therapy |
Ediriwickrima LS and Zaheer W 2011 [5] | 67 | M | DLBCL with lupus anticoagulant | R-CHOP | 2 months | Disappearance of lupus anticoagulant |
Wang J et al. 2020 [19] | 35 cases Mean 46.2 years | 15 M 20 F | Lymphoma (NOS) | Not described | Not described | NR |
Liu JK et al. 2003 [7] | 52 | M | DLBCL | S2-S3 sacral laminectomy+ RCHOP + RT | 4 months | Reduction in size, no metabolic imaging performed |
Liu JK et al. 2003 [7] | 64 | M | DLBCL | 3 cycles of CHOP followed by RT | 13 months | Reduction in size, no metabolic imaging performed |
Thornton E et al 2012 [20] | 53 | M | Lymphoma (NOS) | Not reported | Not reported | Not reported |
Fourati N et al. 2017 [21] | 24 | – | HD | BEACOPP ×2 ABVD ×4 RT | 15 months | CR |
Ha-Ou-Nou F et al 2013 [22] | 35 | M | HD | ABVD | NR | NR |
Ezenekwe AM et al 2004 [23] | 50 | M | Precursor B cell lymphoblastic lymphoma | Carmustine, cyclophosphamide, cytarabine, doxorubicin, etoposide followed by surgical excision | 10 | CR |
Loh JK et al. 2005 [24] | 6 | M | Lymphoma (NOS) | Subtotal resection | 11 years | CR |
Hermann G et al. 1997 [25] | NR | NR | Lymphoma (NOS) | NR | NR | NR |
Theodorou DJ et al 2000 [12] | 58 | M | Monostotic primary non-Hodgkin’s lymphoma of the bone with intrathecal involvement | Combination chemo Intrathecal MTX RT Peripheral blood stem cell transplant | 1 year | CR |
Chaari N et al. 2011 [4] | 49 | F | DLBCL | NR | NR | NR |
Kirsch DG et al. 2005 [26] | 14 | F | HD | Two cycles of vincristine, prednisone, procarbazine, and doxorubicin followed by four cycles of cyclophosphamide, vincristine, prednisone, procarbazine + proton beam RT | 2.5 years | CR |
Ackerman L et al. 1994 [27] | 36 | M | Large cell lymphoma | NR | NR | NR |
Tazi EM et al. 2009 [11] | 45 | M | DLBCL | CHOP +RT | 10 years | CR, later developed histoplasmosis at same site |
Amonkar AP et al. 2017 [3] | 39 | M | GC type DLBCL | RT followed by CHOP | NR | NR |
Mally R et al. 2011 [8] | 24 | M | DLBCL | CHOP Intrathecal MTX RT | 3 months | NR |
Present case | 36 | M | DLBCL | RCHOP Maintenance R RT | 36 months | CR |